The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Gál, L.,
Fóthi, Á.,
Orosz, G. B.,
Nagy, S.,
Than, N. G.,
Orbán, T. I.:
Exosomal small RNA profiling in first-trimester maternal blood explores early molecular pathways of preterm preeclampsia.
Front. Immunol. 15, 1-14, (article identifier: 1321191), 2024.
Gerszi, D.,
Orosz, G. B.,
Török, M.,
Szalay, B.,
Karvaly, G.,
Orosz, L.,
Hetthéssy, J.,
Vásárhelyi, B.,
Török, O.,
Horváth, E. M.,
Várbíró, S.:
Risk Estimation of Gestational Diabetes Mellitus in the First Trimester.
J. Clin. Endocrinol. Metab. 108 (11), e1214-e1223, 2023.
Than, N. G.,
Posta, M.,
Györffy, D.,
Orosz, L.,
Orosz, G. B.,
Rossi, S. W.,
Ambrus-Aikelin, G.,
Szilágyi, A.,
Nagy, S.,
Hupuczi, P.,
Török, O.,
Tarca, A. L.,
Erez, O.,
Papp, Z.,
Romero, R.:
A praeeclampsia korai betegségútvonalai, biomarkerei és négy különböző molekuláris alosztálya.
Nőgyógy. Szülész. Továbbk. Szle. 24 (1), 6-16, 2022.
Than, N. G.,
Posta, M.,
Györffy, D.,
Orosz, L.,
Orosz, G. B.,
Rossi, S. W.,
Ambrus-Aikelin, G.,
Szilágyi, A.,
Nagy, S.,
Hupuczi, P.,
Török, O.,
Tarca, A. L.,
Erez, O.,
Papp, Z.,
Romero, R.:
Early pathways, biomarkers and four distinct molecular subclasses of preeclampsia: the intersection of clinical, pathological and high dimensional biology studies.
Placenta. 125, 10-19, 2022.
Orosz, L.,
Orosz, G. B.,
Veress, L.,
Dósa, D.,
id. Orosz, L.,
Arany, I.,
Fábián, A.,
Medve, L.,
Pap, K.,
Karányi, Z.,
Tóth, Z.,
Póka, R.,
Than, N. G.,
Török, O.:
Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary.
J. Biotechnol. 300, 11-19, 2019.
Chaoui, R.,
Orosz, G. B.,
Heling, K. S.,
Sarut-Lopez, A.,
Nicolaides, K. H.:
Maxillary gap at 11-13 weeks' gestation: marker of cleft lip and palate.
Ultrasound Obstet. Gynecol. 46 (6), 665-669, 2015.
Quezada, M. S.,
Gil, M. M.,
Francisco, C.,
Orosz, G. B.,
Nicolaides, K. H.:
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and?the combined test at 11-13 weeks.
Ultrasound Obstet. Gynecol. 45 (1), 36-41, 2015.
Orosz, L.,
Orosz, G. B.,
Arany, I.,
Fábián, A.,
Pap, K.,
Medve, L.,
Tóth, Z.,
Póka, R.,
Török, O.:
Maternal characteristics, ultrasound- and serum-markers at 11-13+6 weeks in pregnancies without pre-eclampsia resulting small for gestational age neonates.
Ultrasound Obstet. Gynecol. 44 (S1), 264, 2014.
Orosz, L.,
Orosz, G. B.,
Arany, I.,
Fábián, A.,
Pap, K.,
Medve, L.,
Tóth, Z.,
Póka, R.,
Török, O.:
The contribution of PLGF to the performance of screening for severe pre-eclampsia in the first trimester of pregnancy in routine clinical practice.
Ultrasound Obstet. Gynecol. 44 (S1), 270-270, 2014.
Orosz, L.,
Orosz, G. B.,
id. Orosz, L.,
Fábián, A.,
Tóth, Z.,
Török, O.:
Screening for pre-eclampsia during the first trimester in routine clinical practice: a prospective study.
Ultrasound Obstet. Gynecol. 40 (S1), 199-200, 2012.